Position in DXCM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,890,379
+$313,428 QoQ
Shares Held
28,068
+18.1% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#395
of 966 holders
Holding Since
Sep 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026DARK FOREST CAPITAL MANAGEMENT LP holds $15,536,015 across 13 Medical Devices names. DXCM ranks #4 (12.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
98,856 | $4,219,174 | |
| 2 | STE |
STERIS plc
|
10,534 | $2,218,144 | |
| 3 | IRMD |
Iradimed Corp
|
21,579 | $2,062,089 | |
| 4 | DXCM |
Dexcom Inc
This page
|
28,068 | $1,890,379 | |
| 5 | NVCR |
NovoCure Ltd
|
79,908 | $1,210,606 | |
| 6 | BFLY |
Butterfly Network, Inc.
|
84,477 | $711,296 | |
| 7 | BIO |
Bio-Rad Laboratories, Inc.
|
2,219 | $651,520 | |
| 8 | ENOV |
Enovis CORP
|
28,759 | $595,311 |
All Filings in DXCM
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,890,379 | 28,068 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $1,576,951 | 23,760 | Shares | Sole | 2026-02-17 | |
| 2023-06-30 | $267,172 | 2,079 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $6,228 | 55 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $724 | 9 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $596 | 8 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $33,290 | 62 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $64,529 | 118 | Shares | Sole | 2021-11-16 | |
| No filing history on record for this holder in this stock. | ||||||